Tag Archives: health

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?


In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Scientific American WorldView Super Session and the Future of Innovation


The final Super Session of the 2015 BIO International Convention today featured a panel of international luminaries who offered their perspective on the future of innovation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, the panelists provided a fresh perspectives on international life science development and the ways disruptive technologies are changing how we do business and experience the world around us. On the panel: Lee Hood, President of Institute Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Wednesday Recap of BIO 2015: What the Official Bloggers Have to Say

BIO Official Blogger

Everyday our BIO Official Bloggers, writers who are on top of the biotechnology beat, release statements about their experience at the BIO International Convention. Here is what they want to share with you today: Scrip Intelligence By Lisa LaMotta Roche’s strong deal-making position is at least partly due to its acquisition of Genentech, but partnering head Sophie Kornowski-Bonnet explained that the firm is more interested in looking for drugs than bolt-on companies. Read more…   Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Future of Health and Medicine in the Digital Era


Dr. Daniel Kraft is a well-known Stanford and Harvard trained physician-scientist and innovator with over 20 years of clinical, research and innovation experience. He serves as Faculty chair for Medicine at Singularity University and is the Founder and Executive Director of Exponential Medicine. Dr. Kraft concluded the Digital Health Forum with his session titled The Future of Health and Medicine: Where Can Technology Take Us? which offered a fast-paced look at the next few years of innovations in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,